InvestorsObserver
×
News Home

Should AcelRx Pharmaceuticals Inc (ACRX) Stock be in Your Portfolio?

Thursday, October 15, 2020 02:17 PM | InvestorsObserver Analysts

Mentioned in this article

Should AcelRx Pharmaceuticals Inc (ACRX) Stock be in Your Portfolio?

AcelRx Pharmaceuticals Inc (ACRX) stock has fallen -23.64% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ACRX stock a score of 72 out of a possible 100.

That rank is influenced by a long-term technical score of 94. ACRX's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, ACRX stock has a mean target price of 6. This means analysts expect the stock to climb 257.14% over the next 12 months. The short-term technical score for ACRX is 35.

Overall Score - 72
ACRX has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on ACRX!

What's Happening with ACRX Stock Today

AcelRx Pharmaceuticals Inc (ACRX) stock has fallen -9.19% while the S&P 500 has fallen -0.3% as of 2:15 PM on Thursday, Oct 15. ACRX has fallen -$0.17 from the previous closing price of $1.85 on volume of 1,534,054 shares. Over the past year the S&P 500 is higher by 16.34% while ACRX has fallen -23.64%. ACRX lost -$0.62 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on AcelRx Pharmaceuticals Inc (ACRX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App